Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMQLXKK)

Drug Name	OP-145 DMQLXKK
Synonyms	OP-145 CSOM; OPI-45; Endotoxin-neutralizing protein, Leiden UMC/OctoPlus; Otitis media therapy, Leiden UMC/OctoPlus/Green Cross
Drug Type	Peptide

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Otitis media	DISGZDUO	AA80-AB0Z	Phase 2	[1]
Chronic suppurative otitis media	DISPZ8AN	AA91	Phase 2	[1]
------------------------------------------------------------------------------------

1 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Bronchitis	DISBM6EQ	CA20	Discontinued in Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov. 2020 May;19(5):311-332.
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020797)